You are here

SELF EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS): A REVIEW

Journal Name:

Publication Year:

Abstract (2. Language): 
Self-emulsifying drug delivery systems (SEDDS) have gained exposure for their ability to increase solubility and bioavailability of poorly soluble drugs. SEDDS are isotropic mixtures of oils and surfactants, sometimes containing co solvents, and can be used for the design of formulations in order to improve the oral absorption of highly lipophilic compounds. SEDDS emulsify spontaneously to produce fine oil-in-water emulsions when introduced into an aqueous phase under gentle agitation. SEDDS can be orally administered in soft or hard gelatine capsules and form fine, relatively stable oil-in-water emulsions upon aqueous dilution. This article presents an overview of SEDDS and their applications.

REFERENCES

References: 

1. Bhatt PP: Osmotic drug delivery systems for poorly soluble drugs. The Drug Delivery Companies Report Autumn/Winter 2004: 26-29 (Pharma
Ventures Ltd 2004).
2. Burcham DL: Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm. Drug Dispose. 1997; 18: 737-742.
3.Serajuddin TM: Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersion. J. Pharm. Sci.1988; 77: 414-417.
4.Myers RA and Stella VJ: Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int. J.
Pharm.1992; 78: 217-226.
5.Schwendener RA and Schott H: Lipophilic 1-beta-d -arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukaemia model. J. Cancer Res. Clin.
Oncol. 1996; 122: 723-726.
6. Shah NH: Self-emulsifying drug delivery systems (SEDDS) with
polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs," Int. J. Pharm.1994; 106:
15-23.
7. Gursoy RN and Benita S: Self-
emulsifying drug delivery systems for improved oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapy 2004;
58: 173-182.
8. Constantinides PP: Lipid micro emulsion for improving drugs dissolution and oral absorption: physical and biopharmaceutical aspects. Pharma Res.
1995; 12: 1561-1572.
9. Khoo SM: Formulation design and bioavailability assessment of lipidic silf-emulsifying formulation of halofanitrine. International Journal of Pharmaceutics
1998; 167: 155-164.
10. Crison JR and Amidon GL: Method and formulation for increasing the bioavailability of poorly water-soluble
drugs. US Patent No. 5,993,858, issued
November 30, 1999.
11. Farah N, Laforet JP and Denis J: Self
Micro Emulsifying Drug Delivery Systems for improving dissolution of drugs: In vitro evaluations. Presented by Gattefosse Patented Technology at the AAPS Annual Meeting in San Diego, November 1994.12.
Crai
g DQM: An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm. 1995; 114: 103-110.
13.
Gurso
y N: Excipient effects on in vitro cytotoxicity of a novel paclitaxel selfemulsifying drug delivery system," J. Pharm. Sci. 2003; 92: 2420-2427.
14.
Gershani
k T and Benita S, "Positively-charged self-emulsifying oil formulation for improving oral bioavailability of progesterone," Pharm. Dev. Technol. 1996; 1: 147-157.
15.
Tar
r BD and Yalkowsky SH: Enhanced intestinal absorption of
cyclosporine in rats through the reduction of emulsion droplet size," Pharm. Res.
1989; 6: 40-43.
16. Charman SA: Self-emulsifying drug delivery system: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound," Pharma. Res.1992; 9: 87 - 93.
17. Holm R, Jensen IHM, and Sonnergaard J: Optimization of self-micro emulsifying drug delivery system using D-optimal design and the desirability function," Drug Development and Industrial Pharmacy 2006; 32: 1025 -1032.
Available Online

Thank you for copying data from http://www.arastirmax.com